TY - JOUR
T1 - Endocarditis and pericarditis complicating pneumococcal bacteraemia, with special reference to the adhesive abilities of pneumococci
T2 - Results from a prospective study
AU - Kan, B.
AU - Ries, J.
AU - Normark, B. Henriques
AU - Chang, F. Y.
AU - Feldman, C.
AU - Ko, W. C.
AU - Rello, J.
AU - Snydman, D. R.
AU - Yu, V. L.
AU - Ortqvist, Ake
N1 - Funding Information:
Financial support was received from The Swedish Heart-Lung Foundation, Karolinska Institutet and EU 6th Framework Programme PREVIS. This work was presented, in part, at the 4th International Symposium on Pneumococci and Pneumococcal Diseases (Helsinki, 2004).
PY - 2006/4
Y1 - 2006/4
N2 - The incidence of pneumococcal cardiac infections is unknown and the pathogenicity of such complications is poorly understood. In a prospective, international, observational study, eight of 844 patients hospitalised with Streptococcus pneumoniae bacteraemia developed endocarditis (n = 5) or pericarditis (n = 3). The clinical and microbiological characteristics of these patients were compared those of control patients. The corresponding incidence of pneumococcal endocarditis was c. 1-3/1 million inhabitants/year. There was no common pattern in the medical history of patients with an infectious cardiac complication. The severity of illness upon admission was comparable with that for patients without infectious cardiac complications, as was the 14-day mortality rate (25% and 17%, respectively). For encapsulated S. pneumoniae, no significant differences were found between patients with infectious cardiac complications and controls in adherence assays. However, on-encapsulated S. pneumoniae showed higher hydrophobicity and increased adherence to human epithelial cells.
AB - The incidence of pneumococcal cardiac infections is unknown and the pathogenicity of such complications is poorly understood. In a prospective, international, observational study, eight of 844 patients hospitalised with Streptococcus pneumoniae bacteraemia developed endocarditis (n = 5) or pericarditis (n = 3). The clinical and microbiological characteristics of these patients were compared those of control patients. The corresponding incidence of pneumococcal endocarditis was c. 1-3/1 million inhabitants/year. There was no common pattern in the medical history of patients with an infectious cardiac complication. The severity of illness upon admission was comparable with that for patients without infectious cardiac complications, as was the 14-day mortality rate (25% and 17%, respectively). For encapsulated S. pneumoniae, no significant differences were found between patients with infectious cardiac complications and controls in adherence assays. However, on-encapsulated S. pneumoniae showed higher hydrophobicity and increased adherence to human epithelial cells.
UR - http://www.scopus.com/inward/record.url?scp=33644766970&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33644766970&partnerID=8YFLogxK
U2 - 10.1111/j.1469-0691.2006.01363.x
DO - 10.1111/j.1469-0691.2006.01363.x
M3 - Article
C2 - 16524410
AN - SCOPUS:33644766970
SN - 1198-743X
VL - 12
SP - 338
EP - 344
JO - Clinical Microbiology and Infection
JF - Clinical Microbiology and Infection
IS - 4
ER -